Search

Pharmagest Interactive

Закрыт

0

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели

By Trading Economics

Доход

-1.8M

17M

Продажи

7.2M

116M

P/E

Средняя по отрасли

18.368

Дивидендная доходность

2.85

Рентабельность продаж

14.879

Сотрудники

1,400

EBITDA

178M

116M

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.85%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

53M

660M

Предыдущая цена открытия

0

Предыдущая цена закрытия

0

Pharmagest Interactive График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

29 дек. 2025 г., 22:03 UTC

Главные движущие силы рынка

Mining Stocks Slip Near the End of Stellar Year

29 дек. 2025 г., 15:57 UTC

Главные движущие силы рынка

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 дек. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Decline; Yen in Focus -- Market Talk

29 дек. 2025 г., 23:38 UTC

Приобретения, слияния, поглощения

Manus: Will Continue to Operate From Singapore

29 дек. 2025 г., 23:38 UTC

Приобретения, слияния, поглощения

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 дек. 2025 г., 23:37 UTC

Приобретения, слияния, поглощения

Meta Platforms: Will Integrate Manus Service Into Products

29 дек. 2025 г., 23:36 UTC

Приобретения, слияния, поглощения

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 дек. 2025 г., 23:36 UTC

Приобретения, слияния, поглощения

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 дек. 2025 г., 23:35 UTC

Приобретения, слияния, поглощения

Manus to Join Meta Platforms

29 дек. 2025 г., 21:33 UTC

Приобретения, слияния, поглощения

Origin: Raise Values Kraken at US$8.65 Billion

29 дек. 2025 г., 21:33 UTC

Приобретения, слияния, поглощения

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 дек. 2025 г., 21:31 UTC

Приобретения, слияния, поглощения

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 дек. 2025 г., 21:31 UTC

Приобретения, слияния, поглощения

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 дек. 2025 г., 21:30 UTC

Приобретения, слияния, поглощения

Origin's Kraken Stake to Remain at 22.7%

29 дек. 2025 г., 21:30 UTC

Приобретения, слияния, поглощения

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 дек. 2025 г., 21:30 UTC

Приобретения, слияния, поглощения

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 дек. 2025 г., 21:30 UTC

Приобретения, слияния, поглощения

Origin: Additional Interest Offsets Dilution From Raise

29 дек. 2025 г., 21:30 UTC

Приобретения, слияния, поглощения

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 дек. 2025 г., 21:29 UTC

Приобретения, слияния, поглощения

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 дек. 2025 г., 21:29 UTC

Приобретения, слияния, поглощения

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 дек. 2025 г., 21:29 UTC

Приобретения, слияния, поглощения

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 дек. 2025 г., 21:27 UTC

Приобретения, слияния, поглощения

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 дек. 2025 г., 20:22 UTC

Обсуждения рынка

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 дек. 2025 г., 20:14 UTC

Обсуждения рынка

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 дек. 2025 г., 20:02 UTC

Приобретения, слияния, поглощения

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 дек. 2025 г., 17:36 UTC

Обсуждения рынка

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Pharmagest Interactive Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat